Immune-active microenvironment in SCCOHT: Rationale for therapy with immune checkpoint blockade.

被引:0
|
作者
Van Oudenhove, Elke [1 ]
Jelinic, Petar [1 ]
Ricca, Jacob [2 ]
Narciso, Olvera [1 ]
Merghoub, Taha
Levine, Douglas A. [1 ]
Zamarin, Dmitriy [2 ]
机构
[1] NYU, Sch Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1158/1557-3265.OVCA17-B26
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B26
引用
收藏
页码:95 / 95
页数:1
相关论文
共 50 条
  • [41] Immune Checkpoint Blockade
    Naidoo, Jarushka
    Page, David B.
    Wolchok, Jedd D.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (03) : 585 - +
  • [42] Immune Checkpoint Upregulation Following Radiation Therapy: Rationale for Combining Radiation Therapy With Multiple Immune Checkpoint Blockades
    Harris, T. J.
    Jackson, C.
    Gandhi, N.
    Tran, P.
    Drake, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S109 - S110
  • [43] IMMUNE CHECKPOINT BLOCKADE IS ACTIVE IN MELANOMA BRAIN METASTASES
    不详
    CANCER DISCOVERY, 2018, 8 (06) : 672 - 672
  • [44] Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
    Lee, Yu-Hung
    Yu, Ching-Fang
    Yang, Ying-Chieh
    Hong, Ji-Hong
    Chiang, Chi-Shiun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 14
  • [45] Targeting DKK1 to Remodel the Tumor Microenvironment and Enhance Immune Checkpoint Blockade Therapy
    Shi, Tao
    Wei, Jia
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (03)
  • [46] Rationale and Emerging Strategies for Immune Checkpoint Blockade in Soft Tissue Sarcoma
    Wisdom, Amy J.
    Mowery, Yvonne M.
    Riedel, Richard F.
    Kirsch, David G.
    CANCER, 2018, 124 (19) : 3819 - 3829
  • [47] The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment
    Luo, Hong
    Wang, Wenxiang
    Mai, Jia
    Yin, Rutie
    Cai, Xuyu
    Li, Qintong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
    Hargadon, Kristian M.
    Johnson, Coleman E.
    Williams, Corey J.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 62 : 29 - 39
  • [49] The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies
    Keung, Emily Z.
    Ukponmwan, Esosa U.
    Cogdill, Alexandria P.
    Wargo, Jennifer A.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (07) : 1814 - 1827
  • [50] The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies
    Emily Z. Keung
    Esosa U. Ukponmwan
    Alexandria P. Cogdill
    Jennifer A. Wargo
    Annals of Surgical Oncology, 2018, 25 : 1814 - 1827